176 related articles for article (PubMed ID: 10452792)
1. Clinical experience with levalbuterol.
Nelson HS
J Allergy Clin Immunol; 1999 Aug; 104(2 Pt 2):S77-84. PubMed ID: 10452792
[TBL] [Abstract][Full Text] [Related]
2. Levalbuterol and racemic albuterol: are there therapeutic differences?
Ahrens R; Weinberger M
J Allergy Clin Immunol; 2001 Nov; 108(5):681-4. PubMed ID: 11692088
[No Abstract] [Full Text] [Related]
3. Improved bronchodilation with levalbuterol compared with racemic albuterol in patients with asthma.
Nelson HS; Bensch G; Pleskow WW; DiSantostefano R; DeGraw S; Reasner DS; Rollins TE; Rubin PD
J Allergy Clin Immunol; 1998 Dec; 102(6 Pt 1):943-52. PubMed ID: 9847435
[TBL] [Abstract][Full Text] [Related]
4. A cumulative dose study of levalbuterol and racemic albuterol administered by hydrofluoroalkane-134a metered-dose inhaler in asthmatic subjects.
Tripp K; McVicar WK; Nair P; Corren J; Pleskow WW; Goodwin E; Baumgartner RA; Hanrahan JP
J Allergy Clin Immunol; 2008 Sep; 122(3):544-9. PubMed ID: 18692886
[TBL] [Abstract][Full Text] [Related]
5. Prospects for improved therapy in chronic obstructive pulmonary disease by the use of levalbuterol.
Costello J
J Allergy Clin Immunol; 1999 Aug; 104(2 Pt 2):S61-8. PubMed ID: 10452790
[TBL] [Abstract][Full Text] [Related]
6. Levalbuterol versus albuterol.
Ameredes BT; Calhoun WJ
Curr Allergy Asthma Rep; 2009 Sep; 9(5):401-9. PubMed ID: 19671384
[TBL] [Abstract][Full Text] [Related]
7. The safety and efficacy of nebulized levalbuterol compared with racemic albuterol and placebo in the treatment of asthma in pediatric patients.
Gawchik SM; Saccar CL; Noonan M; Reasner DS; DeGraw SS
J Allergy Clin Immunol; 1999 Apr; 103(4):615-21. PubMed ID: 10200010
[TBL] [Abstract][Full Text] [Related]
8. Dose-response evaluation of levalbuterol versus racemic albuterol in patients with asthma.
Handley DA; Tinkelman D; Noonan M; Rollins TE; Snider ME; Caron J
J Asthma; 2000 Jun; 37(4):319-27. PubMed ID: 10883742
[TBL] [Abstract][Full Text] [Related]
9. The asthma-like pharmacology and toxicology of (S)-isomers of beta agonists.
Handley D
J Allergy Clin Immunol; 1999 Aug; 104(2 Pt 2):S69-76. PubMed ID: 10452791
[TBL] [Abstract][Full Text] [Related]
10. Levalbuterol hydrochloride.
Slattery D; Wong SW; Colin AA
Pediatr Pulmonol; 2002 Feb; 33(2):151-7. PubMed ID: 11802253
[TBL] [Abstract][Full Text] [Related]
11. An evaluation of nebulized levalbuterol in stable COPD.
Datta D; Vitale A; Lahiri B; ZuWallack R
Chest; 2003 Sep; 124(3):844-9. PubMed ID: 12970007
[TBL] [Abstract][Full Text] [Related]
12. Pairwise comparison of levalbuterol versus racemic albuterol in the treatment of moderate-to-severe asthma.
Pleskow WW; Nelson HS; Schaefer K; Claus R; Roach JM
Allergy Asthma Proc; 2004; 25(6):429-36. PubMed ID: 15709454
[TBL] [Abstract][Full Text] [Related]
13. Comparison of levalbuterol and racemic albuterol in hospitalized patients with acute asthma or COPD: a 2-week, multicenter, randomized, open-label study.
Donohue JF; Hanania NA; Ciubotaru RL; Noe L; Pasta DJ; Schaefer K; Claus R; Andrews WT; Roach J
Clin Ther; 2008; 30 Spec No():989-1002. PubMed ID: 18640474
[TBL] [Abstract][Full Text] [Related]
14. Levalbuterol: pharmacologic properties and use in the treatment of pediatric and adult asthma.
Berger WE
Ann Allergy Asthma Immunol; 2003 Jun; 90(6):583-91; quiz 591-2, 659. PubMed ID: 12839314
[TBL] [Abstract][Full Text] [Related]
15. Contrasting properties of albuterol stereoisomers.
Page CP; Morley J
J Allergy Clin Immunol; 1999 Aug; 104(2 Pt 2):S31-41. PubMed ID: 10452786
[TBL] [Abstract][Full Text] [Related]
16. Levalbuterol in the treatment of patients with asthma and chronic obstructive lung disease.
Dalonzo GE
J Am Osteopath Assoc; 2004 Jul; 104(7):288-93. PubMed ID: 15293593
[TBL] [Abstract][Full Text] [Related]
17. Levalbuterol nebulizer solution: is it worth five times the cost of albuterol?
Asmus MJ; Hendeles L
Pharmacotherapy; 2000 Feb; 20(2):123-9. PubMed ID: 10678290
[TBL] [Abstract][Full Text] [Related]
18. Low-dose levalbuterol in children with asthma: safety and efficacy in comparison with placebo and racemic albuterol.
Milgrom H; Skoner DP; Bensch G; Kim KT; Claus R; Baumgartner RA;
J Allergy Clin Immunol; 2001 Dec; 108(6):938-45. PubMed ID: 11742271
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the dose response to levalbuterol with and without pretreatment with S-albuterol after methacholine-induced bronchoconstriction.
Raissy HH; Harkins M; Esparham A; Kelly HW
Pharmacotherapy; 2007 Sep; 27(9):1231-6. PubMed ID: 17723076
[TBL] [Abstract][Full Text] [Related]
20. Comparison of racemic albuterol and levalbuterol in the treatment of acute asthma in the ED.
Schreck DM; Babin S
Am J Emerg Med; 2005 Nov; 23(7):842-7. PubMed ID: 16291438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]